{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:19:58Z","timestamp":1793751598638,"version":"4.6.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00208","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T06:13:04Z","timestamp":1584425584000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A Meta-Analysis of Dropout and Metabolic Effects of Antipsychotics in Anorexia Nervosa"],"prefix":"10.3389","volume":"11","author":[{"given":"Carol","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1284","article-title":"The Outcome of Anorexia Nervosa in the 20th Century","volume":"159","author":"Steinhausen","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10393","article-title":"Recovery From Anorexia Nervosa and Bulimia Nervosa at 22-Year Follow-Up","volume":"78","author":"Eddy","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0141076815617651","article-title":"Trends in hospital admission rates for anorexia nervosa in Oxford (1968-2011) and England (1990-2011): database studies","volume":"109","author":"Holland","year":"2016","journal-title":"J R Soc Med"},{"key":"B4","first-page":"2015","article-title":"National Clinical Practice Guideline: eating disorders: core interventions in the treatment and management of anorexia nervosa, bulimia nervosa, and related eating disorders","volume":"9","year":"2004","journal-title":"Natl Inst Clin Excell"},{"key":"B5","unstructured":"Eating disorders: recognition and treatment2018"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718002088","article-title":"Treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Murray","year":"2018","journal-title":"Psychol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD010827","DOI":"10.1002\/14651858.CD010827.pub2","article-title":"Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders","volume":"1","author":"Hay","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031707","article-title":"Survey on self-reported psychotropic drug prescribing practices of eating disorder psychiatrists for the treatment of young people with anorexia nervosa","volume":"9","author":"Beykloo M","year":"2019","journal-title":"BMJ Open"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07691","article-title":"Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis","volume":"73","author":"Kishi","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22059","article-title":"The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis","volume":"46","author":"Lebow","year":"2013","journal-title":"Int J Eat Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40337-014-0027-x","article-title":"Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa","volume":"2","author":"de Vos","year":"2014","journal-title":"J Eat Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000369978","article-title":"Second-generation antipsychotic drugs in anorexia nervosa: a meta-analysis of randomized controlled trials","volume":"84","author":"Dold","year":"2015","journal-title":"Psychother Psychosom"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/psb.1269","article-title":"Drug points: second generation antipsychotics","volume":"14","author":"Chaplain","year":"2014","journal-title":"Prescriber"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0439-2","article-title":"Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa","volume":"51","author":"Watson","year":"2019","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852917000529","article-title":"Psychopharmacological options for adult patients with anorexia nervosa: the patients' and carers' perspectives","author":"Himmerich","year":"2017","journal-title":"CNS Spectr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20661","article-title":"Targets and outcomes of psychotherapies for mental disorders: an overview","volume":"18","author":"Cuijpers","year":"2019","journal-title":"World Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2018.08.018","article-title":"Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the \u2018target experiment' concept in studies of exposures: Rationale and preliminary instrument development","volume":"120","author":"Morgan","year":"2018","journal-title":"Environ Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2307\/2682942","article-title":"The inverse of the Freeman-Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am Stat"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","article-title":"Olanzapine therapy in anorexia nervosa: psychobiological effects","volume":"22","author":"Brambilla","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2007.02.005","article-title":"Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion","volume":"32","author":"Brambilla","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"B27","article-title":"Use of risperidone in adolescent anorexia nervosa","volume":"10","author":"Bianco","year":"2000","journal-title":"Ital J Psychiatry Behav Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial","volume":"176","author":"Attia","year":"2019","journal-title":"Am J Psychiatry"},{"key":"B29","first-page":"197","article-title":"Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial","volume":"27","author":"Spettigue","year":"2018","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22704","article-title":"The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa","volume":"50","author":"Frank","year":"2017","journal-title":"Int J Eat Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125569","article-title":"Atypical antipsychotics as augmentation therapy in anorexia nervosa","volume":"10","author":"Marzola","year":"2015","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/erv.2169","article-title":"Double-blind placebo-controlled trial of quetiapine in anorexia nervosa","volume":"20","author":"Powers","year":"2012","journal-title":"Eur Eat Disord Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711000390","article-title":"Olanzapine versus placebo for out-patients with anorexia nervosa","volume":"41","author":"Attia","year":"2011","journal-title":"Psychol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2011.06.009","article-title":"A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study","volume":"50","author":"Hagman","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0139","article-title":"A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa","volume":"21","author":"Kafantaris","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0131","article-title":"Olanzapine Use for the Adjunctive Treatment of Adolescents with Anorexia Nervosa","volume":"21","author":"Norris","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2010.03.011","article-title":"Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study","volume":"44","author":"Court","year":"2010","journal-title":"J Psychiatr Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0072","article-title":"Low-Dose Olanzapine Monotherapy in Girls with Anorexia Nervosa, Restricting Subtype: Focus on Hyperactivity","volume":"20","author":"Leggero","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am J Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/hup.845","article-title":"An open-label study of quetiapine in anorexia nervosa","volume":"22","author":"Bosanac","year":"2007","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eat.20325","article-title":"Quetiapine in anorexia nervosa patients: an open label outpatient pilot study","volume":"40","author":"Powers","year":"2007","journal-title":"Int J Eat Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1665.2004.02154.x","article-title":"Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa","volume":"13","author":"Mondraty","year":"2005","journal-title":"Australas Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1106","article-title":"An open trial of olanzapine in anorexia nervosa","volume":"65","author":"Barbarich","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10122","article-title":"Olanzapine treatment of anorexia nervosa: a retrospective study","volume":"33","author":"Malina","year":"2003","journal-title":"Int J Eat Disord"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10084","article-title":"Olanzapine in the treatment of anorexia nervosa: an open label trial","volume":"32","author":"Powers","year":"2002","journal-title":"Int J Eat Disord"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-5846(01)00174-9","article-title":"A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics","volume":"25","author":"Ruggiero","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/bf02245617","article-title":"Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial","volume":"124","author":"Beasley","year":"1996","journal-title":"Psychopharmacol (Berl)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/archpsyc.62.12.1305","article-title":"Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs","volume":"62","author":"Kemmler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22850","article-title":"Dropout from cognitive-behavioral therapy for eating disorders: a meta-analysis of randomized, controlled trials","volume":"51","author":"Linardon","year":"2018","journal-title":"Int J Eat Disord"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1590\/S1679-45082016RW3120","article-title":"Effectiveness of psychosocial interventions in eating disorders: an overview of Cochrane systematic reviews","volume":"14","author":"Costa","year":"2016","journal-title":"Einstein (Sao Paulo)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/10503307.2018.1497215","article-title":"Dropout from interpersonal psychotherapy for mental health disorders: a systematic review and meta-analysis","volume":"29","author":"Linardon","year":"2019","journal-title":"Psychother Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T06:13:07Z","timestamp":1584425587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":51,"alternative-id":["10.3389\/fpsyt.2020.00208"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00208","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"article-number":"208"}}